|
Volumn 95, Issue 12, 2017, Pages 771-778
|
Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
NOOTROPIC AGENT;
ALZHEIMER DISEASE;
COMBINATION DRUG THERAPY;
EVIDENCE BASED MEDICINE;
EXERCISE;
HUMAN;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ALZHEIMER DISEASE;
CHOLINESTERASE INHIBITORS;
DOPAMINE AGENTS;
DRUG THERAPY, COMBINATION;
EVIDENCE-BASED MEDICINE;
EXERCISE;
HUMANS;
NOOTROPIC AGENTS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
EID: 85022182691
PISSN: None
EISSN: 15320650
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (72)
|
References (0)
|